Literature DB >> 12783976

Intravascular lymphomatosis.

P C W Lui1, G K C Wong, W S Poon, G M K Tse.   

Abstract

Intravascular lymphomatosis (IVL) is a rare angiotrophic large cell lymphoma producing vascular occlusion of arterioles, capillaries, and venules. Antigenic phenotyping shows that these lymphomas are mostly of B cell type, and less commonly T cell or Ki-1 lymphomas. The central nervous system and skin are the two most commonly affected organs; patients usually present with progressive encephalopathy with mental status changes and focal neurological deficits and skin petechia, purpura, plaques, and discolouration. Other involved organs include adrenal glands, lungs, heart, spleen, liver, pancreas, genital tract, and kidneys. Bone marrow, blood, cerebrospinal fluid, and lymph nodes are typically spared. Fever of unknown origin is another common presentation. Only one case of IVL presenting with disseminated intravascular coagulation and anasarca (generalised oedema) has been reported in the literature. This report describes a postmortem case of a patient with IVL who initially presented with disseminated intravascular coagulation complicated by intracerebral haemorrhage.

Entities:  

Mesh:

Year:  2003        PMID: 12783976      PMCID: PMC1769962          DOI: 10.1136/jcp.56.6.468

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis.

Authors:  M Ponzoni; G Arrigoni; V E Gould; B Del Curto; M Maggioni; A Scapinello; S Paolino; A Cassisa; C Patriarca
Journal:  Hum Pathol       Date:  2000-02       Impact factor: 3.466

Review 2.  Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis.

Authors:  W C Aird
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  Vascular-bed--specific hemostasis and hypercoagulable states.

Authors:  R D Rosenberg; W C Aird
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

4.  Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors.

Authors:  J A Ferry; N L Harris; L J Picker; D S Weinberg; R K Rosales; J Tapia; E P Richardson
Journal:  Mod Pathol       Date:  1988-11       Impact factor: 7.842

5.  Neurologic manifestations of intravascular lymphomatosis.

Authors:  J E Chapin; L E Davis; M Kornfeld; R N Mandler
Journal:  Acta Neurol Scand       Date:  1995-06       Impact factor: 3.209

6.  Malignant angioendotheliomatosis presenting as disseminated intravascular coagulopathy.

Authors:  R L Stahl; W Chan; A Duncan; C C Corley
Journal:  Cancer       Date:  1991-11-15       Impact factor: 6.860

Review 7.  Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy.

Authors:  J A DiGiuseppe; W G Nelson; E J Seifter; J K Boitnott; R B Mann
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

  7 in total
  4 in total

1.  Intravascular lymphomatosis and intracerebral haemorrhage.

Authors:  Maria Grazia Passarin; Patrick Y Wen; Emanuela Vattemi; Ebba Buffone; Claudio Ghimenton; Lamberto Bontempini; Sarah Ottaviani; Anna Maria Musso; Rebecca Pedersini
Journal:  Neurol Sci       Date:  2010-06-02       Impact factor: 3.307

Review 2.  Primary pancreatic lymphoma: what we need to know.

Authors:  Neda Rad; Alireza Khafaf; Amir Houshang Mohammad Alizadeh
Journal:  J Gastrointest Oncol       Date:  2017-08

3.  Secondary Central Nerve System Lymphoma With Intratumoral Hemorrhage Suggested as Intravascular Lymphoma by Autopsy: A Case Report.

Authors:  Yutaro Suzuki; Hiroaki Tanaka; Kennichiro Suyama; Hidetoshi Mochida; Yoshio Suzuki
Journal:  J Clin Med Res       Date:  2017-10-02

4.  MR features of primary and secondary malignant lymphoma of the pancreas: a pictorial review.

Authors:  Yasunari Fujinaga; Chandana Lall; Aashish Patel; Tsuyoshi Matsushita; Rupan Sanyal; Masumi Kadoya
Journal:  Insights Imaging       Date:  2013-03-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.